- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Squamous Lung Cancer With FGFR1 Amplification
Total 790 results
-
Xinqiao Hospital of ChongqingWithdrawn
-
Peking University Cancer Hospital & InstituteUnknownAdvanced Non-squamous Non-small Cell Lung CancerChina
-
Henan Provincial People's HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownStudy of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC (ALTER-L025)Non-squamous Cell Non-Small Cell Lung CancerChina
-
Chang Gung Memorial HospitalTaiwan Chest Disease AssociationCompletedAdvanced Non-Squamous Non-Small Cell Lung CancerTaiwan
-
Qianfoshan HospitalRecruitingAdvanced Non-squamous Non-Small-Cell Lung CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
SanofiActive, not recruitingNon-squamous Non-small-cell Lung Cancer (NSQ NSCLC)Spain, United States, Brazil, Chile, Czechia, France, Hungary, Israel
-
Checkpoint Therapeutics, Inc.TerminatedMetastatic Non-squamous Non Small Cell Lung CancerPeru, Russian Federation, South Africa, New Zealand, Georgia, Thailand, Brazil, Malaysia
-
CanBas Co. Ltd.CompletedMetastatic Non-squamous Non Small Cell Lung CancerUnited States
-
Peking University People's HospitalShanghai Junshi Bioscience Co., Ltd.Not yet recruitingEGFR Positive Non-small Cell Lung Cancer | Non Squamous Non Small Cell Lung Cancer
-
Incyte CorporationZai Lab (Shanghai) Co., Ltd.Active, not recruitingMetastatic Squamous Non-Small Cell Lung Cancer | Metastatic Nonsquamous Non-Small Cell Lung CancerChina, Czechia, Russian Federation, Serbia, Malaysia, Vietnam, United States, Poland, Ukraine, Romania, Turkey, Brazil, Bulgaria, Georgia, Hungary, Philippines, South Africa
-
Washington University School of MedicineEli Lilly and CompanyRecruitingRecurrent Head and Neck Carcinoma | Recurrent Head and Neck Squamous Cell Carcinoma | HNSCC | Recurrent Head and Neck Cancer | Metastatic Head and Neck Cancer | Metastatic Head-and-neck Squamous-cell CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedAdenocarcinoma Lung Cancer; Squamous Cell Lung CarcinomaChina
-
Bristol-Myers SquibbWithdrawn
-
Sung Yong LeeYuhan CorporationRecruitingNon-small Cell Lung Cancer Stage III | Non-squamous Non-small-cell Lung Cancer | EGFR Positive Non-small Cell Lung CancerKorea, Republic of
-
Jonsson Comprehensive Cancer CenterNovartis; Translational Research in OncologyCompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedRenal Cell Carcinoma | Non-Small Cell Lung Cancer | NSCLC | Solid Tumor | Metastatic Cancer | Squamous Cell Carcinoma of the Head and Neck | Urothelial Carcinoma | Squamous Cell Carcinoma | Recurrent CancerUnited States
-
Beijing 302 HospitalRecruitingCOVID-19 | Vaccine Reaction | Patients With CancerChina
-
National Cancer Institute (NCI)CompletedMetastatic Lung Non-Squamous Non-Small Cell Carcinoma | Recurrent Lung Non-Squamous Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7United States
-
National Cancer Institute (NCI)CompletedTongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx and other conditionsUnited States
-
PfizerCompletedOvarian Cancer | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States, Spain
-
AmgenNot yet recruitingAdvanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruitingAdvanced or Metastatic Non-squamous Non-small-cell Lung Cancer
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedNon-Squamous Non-Small Cell Lung CancerChina
-
Erasca, Inc.CompletedAdvanced Non-squamous Non-small-cell Lung CancerUnited States
-
AmgenParexelWithdrawnMetastatic Non-small Cell Lung Cancer (NSCLC) | Non-squamous NSCLC
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerFrance
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerAustralia, France, Germany, Spain, China, Hong Kong, Canada, Sweden, Colombia, Taiwan, United Kingdom, Russian Federation, Finland, Austria, Estonia, Hungary, Netherlands, Latvia, Italy, Mexico, Slovenia, Turkey, Bosnia and Herzegovina and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerFrance, Germany, Spain, Sweden, Russian Federation, Greece, Switzerland, Korea, Republic of, Italy, Netherlands, Turkey, United Arab Emirates
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBulgaria
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBelgium, Spain, United Kingdom, Germany, Italy, Poland, France
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerChina, Hong Kong, Taiwan, Philippines, Thailand, Korea, Republic of, Indonesia
-
Yung Shin Pharm. Ind. Co., Ltd.National Cheng-Kung University Hospital; Tri-Service General Hospital; Taichung...CompletedSquamous Cell Carcinoma of the Head and Neck | Nonsmall Cell Lung Cancer
-
Juntendo UniversityMerck Sharp & Dohme LLCActive, not recruitingNon-squamous Non-small-cell Lung Cancer | EGFR Activating MutationJapan
-
SCRI Development Innovations, LLCAchieve Life SciencesCompletedNon Squamous Non Small Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain
-
AstraZenecaTerminatedPreviously Untreated Stage IV Non-Squamous Non Small Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBelgium, Israel, Italy, Spain, Hong Kong, Taiwan, Canada, France, Greece, Russian Federation, Czech Republic, Australia, Bulgaria, Germany, Thailand, Hungary, United Kingdom, Argentina, Brazil, Poland
-
PD Dr. med. Wolfgang SchuetteEli Lilly and Company; Roche Pharma AGCompletedNon-squamous Non-small Cell Lung CancerGermany
-
M.D. Anderson Cancer CenterOSI PharmaceuticalsWithdrawn
-
AmgenNot yet recruitingEarly-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
-
Shanghai Institute Of Biological ProductsCancer Institute and Hospital, Chinese Academy of Medical SciencesCompletedNon-squamous Non-small-cell Lung CancerChina
-
Hoffmann-La RocheTerminatedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Belgium, Germany, Spain, Australia, Canada, United Kingdom, France, Poland, Ireland
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
Affiliated Hospital of Hebei UniversityUnknownNon-squamous Non-small Cell Lung CancerChina
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, France, Austria, Denmark, Italy, Spain, Germany, Mexico, Netherlands, Japan, Brazil, Greece, Argentina, Slovakia, Lebanon, Belgium, Oman, United Arab Emirates
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerNetherlands
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerAustralia, United States, Hungary, France, Germany, Czech Republic, Poland
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed